Vitamin D and infectious diseases in the COVID-19 pandemic outburst

Detalhes bibliográficos
Autor(a) principal: Silvino, Valmir Oliveira
Data de Publicação: 2020
Outros Autores: Pereira, Mayara Maria Lima, Moura, Rayane Carvalho de, Batista, Mara Cristina Carvalho, Rosa, Bruno Viana, Moura, Eduardo Henrique de, Martins, Maria do Carmo Carvalho e, Santos, Marcos Antônio Pereira dos
Tipo de documento: Artigo
Idioma: por
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/4614
Resumo: The new coronavirus pandemic disease (COVID-19) pandemic was first reported in Wuhan, China, in late 2019, and rapidly spread around the world. Considering its fast transmission rate, the new COVID-19 has become a threat to the public health worldwide. Thus, objective ideas based on scientific evidences must be proposed for the treatment of patients infected. Vitamin D is a hormone with important role in the regulation of the immune system functioning. The main sources of Vitamin D are food intake and synthesis process in the organism which starts in the skin through photoreaction with sun exposure. Then, the pre-Vitamin D is isomerized into pro-Vitamin D. Afterwards, it is metabolized in the liver into 25-hydroxivitamin D, and then converted into in the kidney into its active form, the 1.25-dihydroxivitamin D. Due to its pivotal role in the improvement of the immune response, Vitamin D can positively affect the treatment of several infecto-contagious diseases, such as influenza and H1N1.  This concise review aims to inform about the use of Vitamin D as a possible ally in the treatment of COVID-19. The studies included in this review point out that Vitamin D can perform immunomodulatory and anti-inflammatory functions, which would significantly improve the treatment of viral infections.  Further clinical trials and large populational studies should be carried out in order to better elucidate the effective role of Vitamin D in the treatment of patients with COVID-19.
id UNIFEI_45f228fa5233f0a9ab38bb250e534f1d
oai_identifier_str oai:ojs.pkp.sfu.ca:article/4614
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Vitamin D and infectious diseases in the COVID-19 pandemic outburstVitamina D y enfermedades infectocontagiosas en la pandemia de COVID-19Vitamina D e doenças infectocontagiosas na pandemia da COVID-19SARSCoronavírusTratamentoH1N1Influenza.SARSCoronavirusTratamientoH1N1Influenza.SARSCoronavirusTreatmentH1N1Influenza.The new coronavirus pandemic disease (COVID-19) pandemic was first reported in Wuhan, China, in late 2019, and rapidly spread around the world. Considering its fast transmission rate, the new COVID-19 has become a threat to the public health worldwide. Thus, objective ideas based on scientific evidences must be proposed for the treatment of patients infected. Vitamin D is a hormone with important role in the regulation of the immune system functioning. The main sources of Vitamin D are food intake and synthesis process in the organism which starts in the skin through photoreaction with sun exposure. Then, the pre-Vitamin D is isomerized into pro-Vitamin D. Afterwards, it is metabolized in the liver into 25-hydroxivitamin D, and then converted into in the kidney into its active form, the 1.25-dihydroxivitamin D. Due to its pivotal role in the improvement of the immune response, Vitamin D can positively affect the treatment of several infecto-contagious diseases, such as influenza and H1N1.  This concise review aims to inform about the use of Vitamin D as a possible ally in the treatment of COVID-19. The studies included in this review point out that Vitamin D can perform immunomodulatory and anti-inflammatory functions, which would significantly improve the treatment of viral infections.  Further clinical trials and large populational studies should be carried out in order to better elucidate the effective role of Vitamin D in the treatment of patients with COVID-19.La nueva pandemia de la enfermedad coronavirus (COVID-19) surgió a fines de 2019 en Wuhan, China, y se extendió rápidamente por todo el mundo. Teniendo en cuenta su velocidad de transmisión rápida, COVID-19 se ha convertido en una amenaza para la salud pública en todo el mundo. Por lo tanto, se deben proponer ideas objetivas basadas en evidencia científica para el tratamiento de pacientes infectados. La vitamina D es una hormona que juega un papel importante en la regulación de la función del sistema inmune. Las principales fuentes de obtención de vitamina D son los alimentos y el proceso de síntesis en el cuerpo iniciado en la piel, a través de la fotorreacción mediada por la luz solar, en la que la pre-vitamina D se isomeriza en pro-vitamina D. Posteriormente, se metaboliza en el hígado a 25-hidroxivitamina D, y convertida al riñón en su forma activa, 1,25-dihidroxivitamina D. Debido a su papel clave en la mejora de la respuesta inmune, la vitamina D puede afectar positivamente el tratamiento de diversas enfermedades infecciosas, tales como influenza y H1N1. Esta revisión tiene como objetivo informar sobre el uso de vitamina D como un posible aliado en el tratamiento de COVID-19. Los estudios incluidos en esta revisión indican que la vitamina D puede tener funciones inmunomoduladoras y antiinflamatorias, lo que beneficia significativamente el tratamiento de las infecciones virales. Se recomienda que se realicen ensayos clínicos aleatorios y grandes estudios de población para ayudar a dilucidar el papel efectivo de la vitamina D en el tratamiento de pacientes con COVID-19.A pandemia da doença do novo coronavírus (COVID-19) surgiu no fim de 2019 em Wuhan, China, e rapidamente se alastrou ao redor de todo o globo. Considerando sua rápida taxa de transmissão, a COVID-19 tornou-se uma ameaça à saúde pública mundial. Portanto, ideias objetivas baseadas em evidências científicas devem ser propostas para o tratamento de pacientes infectados. A vitamina D é um hormônio que apresenta função importante na regulação da função do sistema imune. As principais fontes de obtenção da Vitamina D são a alimentação e do processo de síntese no organismo iniciado na pele,  através de fotorreação mediada pela luz solar, em que a pré-vitamina D isomeriza-se em pró-vitamina D. Posteriormente, é metabolizada no fígado em 25-hidroxivitamina D, e convertida no rim em sua forma ativa,  a 1,25-dihidroxivitamina D. Por conta do seu papel chave na melhoria da resposta imune, a Vitamina D pode afetar positivamente o tratamento de diversas doenças infectocontagiosas, tais como a influenza e H1N1. Esta revisão tem como objetivo informar sobre o uso de Vitamina D como possível aliado no tratamento da COVID-19. Os estudos incluídos nesta revisão apontam que a vitamina D pode exercer funções imunomoduladoras e anti-inflamatórias, que beneficiam significativamente o tratamento de infecções virais. Recomenda-se que ensaios clínicos randomizados e estudos populacionais amplos sejam conduzidos para melohr elucidar o papel efetivo da Vitamina D no tratamento de pacientes com COVID-19.Research, Society and Development2020-06-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/461410.33448/rsd-v9i7.4614Research, Society and Development; Vol. 9 No. 7; e771974614Research, Society and Development; Vol. 9 Núm. 7; e771974614Research, Society and Development; v. 9 n. 7; e7719746142525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/4614/4183Copyright (c) 2020 Valmir Oliveira Silvino, Mayara Maria Lima Pereira, Rayane Carvalho de Moura, Mara Cristina Carvalho Batista, Bruno Viana Rosa, Eduardo Henrique de Moura, Maria do Carmo Carvalho e Martins, Marcos Antônio Pereira dos Santosinfo:eu-repo/semantics/openAccessSilvino, Valmir OliveiraPereira, Mayara Maria LimaMoura, Rayane Carvalho deBatista, Mara Cristina CarvalhoRosa, Bruno VianaMoura, Eduardo Henrique deMartins, Maria do Carmo Carvalho eSantos, Marcos Antônio Pereira dos2020-08-20T18:05:03Zoai:ojs.pkp.sfu.ca:article/4614Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:28:24.637298Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Vitamin D and infectious diseases in the COVID-19 pandemic outburst
Vitamina D y enfermedades infectocontagiosas en la pandemia de COVID-19
Vitamina D e doenças infectocontagiosas na pandemia da COVID-19
title Vitamin D and infectious diseases in the COVID-19 pandemic outburst
spellingShingle Vitamin D and infectious diseases in the COVID-19 pandemic outburst
Silvino, Valmir Oliveira
SARS
Coronavírus
Tratamento
H1N1
Influenza.
SARS
Coronavirus
Tratamiento
H1N1
Influenza.
SARS
Coronavirus
Treatment
H1N1
Influenza.
title_short Vitamin D and infectious diseases in the COVID-19 pandemic outburst
title_full Vitamin D and infectious diseases in the COVID-19 pandemic outburst
title_fullStr Vitamin D and infectious diseases in the COVID-19 pandemic outburst
title_full_unstemmed Vitamin D and infectious diseases in the COVID-19 pandemic outburst
title_sort Vitamin D and infectious diseases in the COVID-19 pandemic outburst
author Silvino, Valmir Oliveira
author_facet Silvino, Valmir Oliveira
Pereira, Mayara Maria Lima
Moura, Rayane Carvalho de
Batista, Mara Cristina Carvalho
Rosa, Bruno Viana
Moura, Eduardo Henrique de
Martins, Maria do Carmo Carvalho e
Santos, Marcos Antônio Pereira dos
author_role author
author2 Pereira, Mayara Maria Lima
Moura, Rayane Carvalho de
Batista, Mara Cristina Carvalho
Rosa, Bruno Viana
Moura, Eduardo Henrique de
Martins, Maria do Carmo Carvalho e
Santos, Marcos Antônio Pereira dos
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Silvino, Valmir Oliveira
Pereira, Mayara Maria Lima
Moura, Rayane Carvalho de
Batista, Mara Cristina Carvalho
Rosa, Bruno Viana
Moura, Eduardo Henrique de
Martins, Maria do Carmo Carvalho e
Santos, Marcos Antônio Pereira dos
dc.subject.por.fl_str_mv SARS
Coronavírus
Tratamento
H1N1
Influenza.
SARS
Coronavirus
Tratamiento
H1N1
Influenza.
SARS
Coronavirus
Treatment
H1N1
Influenza.
topic SARS
Coronavírus
Tratamento
H1N1
Influenza.
SARS
Coronavirus
Tratamiento
H1N1
Influenza.
SARS
Coronavirus
Treatment
H1N1
Influenza.
description The new coronavirus pandemic disease (COVID-19) pandemic was first reported in Wuhan, China, in late 2019, and rapidly spread around the world. Considering its fast transmission rate, the new COVID-19 has become a threat to the public health worldwide. Thus, objective ideas based on scientific evidences must be proposed for the treatment of patients infected. Vitamin D is a hormone with important role in the regulation of the immune system functioning. The main sources of Vitamin D are food intake and synthesis process in the organism which starts in the skin through photoreaction with sun exposure. Then, the pre-Vitamin D is isomerized into pro-Vitamin D. Afterwards, it is metabolized in the liver into 25-hydroxivitamin D, and then converted into in the kidney into its active form, the 1.25-dihydroxivitamin D. Due to its pivotal role in the improvement of the immune response, Vitamin D can positively affect the treatment of several infecto-contagious diseases, such as influenza and H1N1.  This concise review aims to inform about the use of Vitamin D as a possible ally in the treatment of COVID-19. The studies included in this review point out that Vitamin D can perform immunomodulatory and anti-inflammatory functions, which would significantly improve the treatment of viral infections.  Further clinical trials and large populational studies should be carried out in order to better elucidate the effective role of Vitamin D in the treatment of patients with COVID-19.
publishDate 2020
dc.date.none.fl_str_mv 2020-06-12
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/4614
10.33448/rsd-v9i7.4614
url https://rsdjournal.org/index.php/rsd/article/view/4614
identifier_str_mv 10.33448/rsd-v9i7.4614
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/4614/4183
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 9 No. 7; e771974614
Research, Society and Development; Vol. 9 Núm. 7; e771974614
Research, Society and Development; v. 9 n. 7; e771974614
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052650583228416